Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Charles River Laboratories Inc
EIR
•Charles River Laboratories Inc•April 3, 2019

Charles River Laboratories Inc – FDA EIR, Apr 3, 2019

Record Details

An FDA surveillance inspection of Charles River Laboratories Inc. in Horsham, PA, was conducted from March 25 to April 3, 2019. This Prescription Drug User Fee Act (PDUFA) inspection specifically targeted the company's nonclinical laboratory operations, adhering to Good Laboratory Practice (GLP) regulations as outlined in Compliance Program 7348.808 and overseen by the Center for Biologics Evaluation and Research (CBER).

The inspection encompassed a thorough review of three animal research studies, examining protocols, raw data, and final reports. Auditors also assessed the firm's organizational structure, personnel qualifications, quality assurance systems, facility maintenance, equipment calibration, and adherence to Standard Operating Procedures. Interactions with various staff members and observations of animal care demonstrations were integral to the review.

Significantly, the inspection concluded without identifying any objectionable conditions or main findings. No FDA Form 483, which details observations of potential regulatory violations, was issued. Therefore, Charles River Laboratories Inc. received a "no action indicated" classification, confirming compliance with the regulatory framework and requiring no specific remedial actions from the company. This positive outcome is consistent with their previous inspection classification.

Company
Charles River Laboratories Inc
Inspection date
April 3, 2019
Product type
biologics
Office
Philadelphia District Office
People
  • Nancy Catricks (company_representative)
  • Stephanie C. Mangigian (investigator)
  • Brad W. Neiswender (recipient)
  • Elise M. Lewis (company_representative)
  • Lisa Sottolano (company_representative)
View Company Profile

ID · d4888e88-f7c0-4b20-b9de-fb15787c1574

Violation Codes1
21 CFR 58

Full citation text and observation details available on the Dashboard.

Other documents for Charles River Laboratories Inc
  • 483 - 2025-10-17October 17, 2025
  • 483 - 2025-02-07February 7, 2025
  • 483 - 2024-10-11October 11, 2024
  • 483 - 2023-08-25August 25, 2023
  • EIR - 2020-09-21September 21, 2020

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Charles River Laboratories Inc
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.